Skip to main content
NCBI home page
Journal of Chiropractic Medicine logoLink to Journal of Chiropractic Medicine
. 2003;2(1):25–36. doi: 10.1016/S0899-3467(07)60070-6

Connective tissue: Vascular and hematological (blood) support

Nick Calvino a,*
PMCID: PMC2646954  PMID: 19674592

Abstract

Connective Tissue (CT) is a ubiquitous component of all major tissues and structures of the body (50% of all body protein is CT), including that of the blood, vascular, muscle, tendon, ligament, fascia, bone, joint, IVD's (intervertebral discs) and skin. Because of its ubiquitous nature, CT is an often overlooked component of any essential nutritional program that may address the structure, and/or function of these tissues. The central role of CT in the health of a virtually all cells, tissues, organs, and organ systems, is discussed. General nutritional CT support strategies, as well as specific CT support strategies that focus on blood, vascular, structural system (eg, muscles, tendons, ligaments, fascia, bone, and joints), integument (skin) and inflammatory and immune mediation will be discussed here and will deal with connective tissue dynamics and dysfunction. An overview of the current scientific understanding and possible options for naturally enhancing the structure and function of CT through the application of these concepts will be discussed in this article, with specific attention on the vascular and hematological systems.

References

  • 1.Houston MC. The role of vascular biology, nutrition and nutraceuticals in the prevention and treatment of hypertension. JANA. 2000;5(Suppl 1):5–71. [Google Scholar]
  • 2.Brown AA, Hu FB. Dietary modulation of endothelia function: Implications for cardiovascular disease. Am J Clin Nutr. 2001;73:673–686. doi: 10.1093/ajcn/73.4.673. [DOI] [PubMed] [Google Scholar]
  • 3.Kleid JJ. L-arginine and its role in cardiovascular diseases. JANA. 2000;3:57–60. [Google Scholar]
  • 4.Korbut R. Effect of L-arginine on plasminogen-activator inhibitor in hypertensive patients with hypercholesterolemia. N England J Med. 1993;328:287–288. doi: 10.1056/nejm199301283280418. [DOI] [PubMed] [Google Scholar]
  • 5.Tarry WC. L-arginine improves endothelium-dependent vasorelaxation and reduces initial hyperplasia after ballon angioplasty. Arteriosclerosis Thrombosis. 1994;14:938–943. doi: 10.1161/01.atv.14.6.938. [DOI] [PubMed] [Google Scholar]
  • 6.Lee TJ, Yu JG. L-Citrulline recycle for synthesis of NO in cerebral perivascular nerves and endothelial cells. Ann N Y Acad Sci. 2002;962:73–80. doi: 10.1111/j.1749-6632.2002.tb04057.x. [DOI] [PubMed] [Google Scholar]
  • 7.Rucker RB, Kosonen T, Clegs MS, Mitchell AE, Rucker BR, Uriu-Hare JY, Keen CL. Copper, lysyl oxidase, and extracellular matrix protein crosslinking. Am J Clin Nutr. 1998;67(Suppl):996S–1002S. doi: 10.1093/ajcn/67.5.996S. [DOI] [PubMed] [Google Scholar]
  • 8.Uay R, Olivares M, Gonzalez M. Essentially of copper in humans. Am J Clin Nutr. 1998;67(Suppl):952S–959S. doi: 10.1093/ajcn/67.5.952S. [DOI] [PubMed] [Google Scholar]
  • 9.Widman L, Wester PO, Stegmayr BK, Wirell M. The dose-dependent reduction in blood pressure through administration of magnesium: A doubleblind placebo controlled cross-over study. Am J Hypertension. 1993;6:41–45. doi: 10.1093/ajh/6.1.41. [DOI] [PubMed] [Google Scholar]
  • 10.McCarron DA, Morris CD, Henry HJ, Stanton JL. Blood pressure and nutrient intake in the United States. Science. 1984;224:1392–1398. doi: 10.1126/science.6729459. [DOI] [PubMed] [Google Scholar]
  • 11.Kinghorn NM, Norris CS, Paterson GR, Otter DE. Comparison of capillary electrophoresis with traditional methods to analyze bovine whey proteins. J Chromatogr A. 1995;700:111–123. doi: 10.1016/0021-9673(95)00117-6. [DOI] [PubMed] [Google Scholar]
  • 12.Morr CV, Ha EY. Whey protein concentrates and isolates: processing and functional properties. Crit Rev Food Sci Nutr. 1993;33:431–476. doi: 10.1080/10408399309527643. [DOI] [PubMed] [Google Scholar]
  • 13.Kume S, Tanabe S. Effect of supplemental lactoferrin with ferrous iron on iron status of newborn calves. J Diary Sci. 1996;79:459–464. doi: 10.3168/jds.s0022-0302(96)76386-5. [DOI] [PubMed] [Google Scholar]
  • 14.Chierici R, Sawatzki G, Tamisari L, Volpato S, Vigi V. Supplementation of an adapted formula with boving lactoferrin. 2. Effects on serum iron, ferritin and zinc levels. Acta Paediatr. 1992;81:475–479. doi: 10.1111/j.1651-2227.1992.tb12277.x. [DOI] [PubMed] [Google Scholar]
  • 15.See D, Mason S, Roshan R. Increased tumor necrosis factor alpha (TNFalpha) and natural killer cell (NK) function using an integrative approach in late stage cancers. Immunol Invest. 2002;31:137–153. doi: 10.1081/imm-120004804. [DOI] [PubMed] [Google Scholar]
  • 16.Rath M, Pauling L. A unified theory of human cardiovascular disease leading the way to the abolition of this disease as a cause for human mortality. J Orthomolecular Med. 1992;7:5–15. [Google Scholar]
  • 17.Mahmoodian F, Peterkofsky B. Vitamin C deficiency in guinea pigs differentially affects the expression of type IV collagen, laminin, and elastin in blood vessels. J Nutr. 1999;129:83–91. doi: 10.1093/jn/129.1.83. [DOI] [PubMed] [Google Scholar]
  • 18.Niedzwiecki A, Ivanov V. Direct and extracellular matrix mediated effect of ascorbate on vascular smooth muscle cell proliferation. 24th AAA (age) and 9th American College of Clinical Gerontology Meeting. Washington, DC; 1994.
  • 19.Gokce N, Keaney JF, Frei B, Holbrook M, Olesiak M, Zachariach BJ. Long-term ascorbic acid administration reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 1999;99:3234–3240. doi: 10.1161/01.cir.99.25.3234. [DOI] [PubMed] [Google Scholar]
  • 20.Loshak D. Effect of vitamin C on aggregation of Human Platelets in smokers and nonsmokers. Medizinische Klinik. 2002;97:263–269. doi: 10.1007/s00063-002-1152-x. [DOI] [PubMed] [Google Scholar]
  • 21.Zhang J. A single high dose of vitamin C counteracts the acute negative effect on microcirculation induced by smoking a cigarette. Microvasc Res. 1999;58:305–311. doi: 10.1006/mvre.1999.2183. [DOI] [PubMed] [Google Scholar]
  • 22.Wilkinson IB. Oral vitamin C reduces arterial stiffness and platelet aggregation in humans. J Cardiovascular Pharmacol. 1999;34:690–693. doi: 10.1097/00005344-199911000-00010. [DOI] [PubMed] [Google Scholar]
  • 23.Sokoloff B, Hori M, Saelhof CC, Wrzolek T, Imai T. Aging, atherosclerosis and ascorbic acid metabolism. J Am Gerontology Society. 1966;14:1239–1260. doi: 10.1111/j.1532-5415.1966.tb02925.x. [DOI] [PubMed] [Google Scholar]
  • 24.Nijveldt RJ, van Nood E, van Hoom DE, Boeleno PG, van Norren K, van Leeuwen PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr. 2001;74:418–425. doi: 10.1093/ajcn/74.4.418. [DOI] [PubMed] [Google Scholar]
  • 25.Keli SO. Dietary flavonoids, antioxidant vitamins, and incidence of stroke. Arch Intern Med. 1996;154:637–642. [PubMed] [Google Scholar]
  • 26.Janssen K, Mensink RP, Cox FJ, Hanyvan JL, Hovenier R, Hollman PC, Katan MB. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr. 1998;67:255–262. doi: 10.1093/ajcn/67.2.255. [DOI] [PubMed] [Google Scholar]
  • 27.Noroozi M, Angerson WJ, Lead MEJ. Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am J Clin Nutr. 1998;67:1210–1218. doi: 10.1093/ajcn/67.6.1210. [DOI] [PubMed] [Google Scholar]
  • 28.Brown AA, Hu FB. Dietary modulation of endothelia function: Implications for cardiovascular disease. Am J Clin Nutr. 2001;73:673–686. doi: 10.1093/ajcn/73.4.673. [DOI] [PubMed] [Google Scholar]
  • 29.Nappo F. Impairment of endothelial functions by acute hyperhomocystinemia and reversal by antioxidant vitamins. JAMA. 1999;281:2113–2118. doi: 10.1001/jama.281.22.2113. [DOI] [PubMed] [Google Scholar]
  • 30.Mietus-Snyder M, Mallow MJ. Endothelial dysfunction occurs in children with two genetic hyperlipidemias: Improvement with antioxidant vitamin therapy. J Pediatrics. 1998;133 doi: 10.1016/s0022-3476(98)70174-x. [DOI] [PubMed] [Google Scholar]
  • 31.Salonen JT, Salonen R, Sepäneen K, Rinta-Kiikka S, Kuukka M, Korpela H, Alfthan G, Kantola M, Schalch W. Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status. Am J Clinical Nutr. 1991;53:1222–1229. doi: 10.1093/ajcn/53.5.1222. [DOI] [PubMed] [Google Scholar]
  • 32.Bostom AG. Nonfasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch Intern Med. 1999;159:1077–1080. doi: 10.1001/archinte.159.10.1077. [DOI] [PubMed] [Google Scholar]
  • 33.McCully KS. The role of homocysteine in atherogenesis. JANA. 2000;3:51–56. [Google Scholar]
  • 34.Verhoef P, Kok FJ, Kruyssen DA, Schouten EG, Witteman JC, Grobbee DE, Ueland PM, Refsum H. Arteriosclerosis, thrombosis & vascular biology. 1997;17:989–995. doi: 10.1161/01.atv.17.5.989. [DOI] [PubMed] [Google Scholar]
  • 35.Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Veland PM. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775–1781. doi: 10.1001/jama.1997.03540460039030. [DOI] [PubMed] [Google Scholar]
  • 36.Malinow MR, Nitro FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arteriosclerosis, Thrombosis & Vascular Biology. 1997;17:1157–1162. doi: 10.1161/01.atv.17.6.1157. [DOI] [PubMed] [Google Scholar]
  • 37.Miller AL, Kelly GS. Homocysteine metabolism – nutritional modulation and impact on health and disease. Alt Med Rev. 1997;2:234–254. [Google Scholar]
  • 38.Kelly GS. The coenzyme forms of vitamin B12: Toward an understanding of their therapeutic potential. Alt Med Rev. 1997;2:459–471. [Google Scholar]
  • 39.Miller AL, Kelly GS. Methionine and homocysteine metabolism and the nutritional prevention of certain birth defects and complications of pregnancy. Alt Med Rev. 1996;1:220–235. [Google Scholar]
  • 40.Motulsky AG. Nutritional ecogenetics: homocysteine related arteriosclerotic vascular disease, neural tube defects, and folic acid. Am J Hum Genet. 1996;58:17–20. [PMC free article] [PubMed] [Google Scholar]
  • 41.Delvin EE, Rozen A, Merouani A, Genest J, Lambert M. Influence of methylenetetrahydrofolate reductase genotype, age, vitamin B-12, and folate status on plasma homocysteine in children. Am J Clin Nutr. 2000;72:1469–1473. doi: 10.1093/ajcn/72.6.1469. [DOI] [PubMed] [Google Scholar]
  • 42.McKinley MC. Low-dose vitamin B-6 effectively lowers fasting plasma homocysteine in healthy elderly persons who are folate and riboflavin replete. Am J Clin Nutr. 2001;73:759–764. doi: 10.1093/ajcn/73.4.759. [DOI] [PubMed] [Google Scholar]
  • 43.Cook RJ. Defining the steps of the folate one-carbon shuffle and homocysteine metabolism. Am J Clin Nutr. 2000;72:1419–1420. doi: 10.1093/ajcn/72.6.1419. [DOI] [PubMed] [Google Scholar]
  • 44.Rath M, Pauling L. Hypothesis: lipoprotein(a) is a surrogate for ascorbate. Proc Natl Acad Sci USA. 1990;87:6204–6207. doi: 10.1073/pnas.87.16.6204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Rath M, Pauling L. Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig. Proc Natl Acad Sci USA. 1990;87:9388–9390. doi: 10.1073/pnas.87.23.9388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Deull PB. Homocysteine: An important risk factor for atherosclerotic vascular disease. Current Opinion in Lipidology. 1997;8:28–34. doi: 10.1097/00041433-199702000-00007. [DOI] [PubMed] [Google Scholar]
  • 47.Graham IM. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA. 1997;277:1775–1781. doi: 10.1001/jama.1997.03540460039030. [DOI] [PubMed] [Google Scholar]
  • 48.Cheng SW, Ting AC, Wong J. Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease. Annals Vascular Surgery. 1997;11:217–223. doi: 10.1007/s100169900037. [DOI] [PubMed] [Google Scholar]
  • 49.Selhub J. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N England J Med. 1995;332:374. doi: 10.1056/NEJM199502023320502. 369. [DOI] [PubMed] [Google Scholar]
  • 50.Konecky N. Correlation between plasma homocysteine and aortic atherosclerosis. Am Heart J. 1997;133:249–256. [Google Scholar]
  • 51.Penix LP. Ischemic strokes secondary to vitamin B12 deficiency-induced hyperhomocystinemia. Neurol. 1998;51:622–624. doi: 10.1212/wnl.51.2.622. [DOI] [PubMed] [Google Scholar]
  • 52.Olthof MR, Hollman PC, Zock PL, Katan MB. Consumption of high doses of chlorogenic acid, present in coffee, or of black tea increases plasma total homocysteine concentrations in humans. Am J Clin Nutr. 2001;73:532–538. doi: 10.1093/ajcn/73.3.532. [DOI] [PubMed] [Google Scholar]
  • 53.Blom HJ. Determinants of plasma homocysteine. Am J Clin Nutr. 1998;67:188–189. doi: 10.1093/ajcn/67.2.188. [DOI] [PubMed] [Google Scholar]
  • 54.Jacques PF. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr. 2001;3:613–621. doi: 10.1093/ajcn/73.3.613. [DOI] [PubMed] [Google Scholar]
  • 55.Koehler KM. Association of folate intake and serum homocysteine in elderly persons according to vitamin supplementation and alcohol user. Am J Clin Nutr. 2001;73:628–637. doi: 10.1093/ajcn/73.3.628. [DOI] [PubMed] [Google Scholar]
  • 56.Morris MS, Jacques PF, Rosenberg IH, Selhub S. Hyperhomocystinemia associated with poor recall in the third National Health and Nutrition Examination Survey. Am J Clin Nutr. 2001;73:927–933. doi: 10.1093/ajcn/73.5.927. [DOI] [PubMed] [Google Scholar]
  • 57.Halsted Ch. Lifestyle effects on homocysteine and an alcohol paradox. Am J Clin Nutr. 2001;73:501–502. doi: 10.1093/ajcn/73.3.501. [DOI] [PubMed] [Google Scholar]
  • 58.Bottiglieria T, Laundy M, Crellin R, Toone BK, Carney MW, Reynolds EH. Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry. 2000;69:228–232. doi: 10.1136/jnnp.69.2.228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Nappo F. Impairment of endothelial functions by acute hyperhomocystinemia and reversal by antioxidant vitamins. JAMA. 1999;281:2113–2118. doi: 10.1001/jama.281.22.2113. [DOI] [PubMed] [Google Scholar]
  • 60.Freyburger G, Labrouche S, Sassoust G, Rouanet F, Javorschi S, Parroth F. Mild hyperhomocystinemia and hemostatic factors in patients with arterial vascular diseases. Thrombosis & hemostasis. 1997;77:466–471. [PubMed] [Google Scholar]
  • 61.Woodside JV, Yarnell JW, McMaster D, Young IS, Harmon DL, McCrum EE. Effect of B-group vitamins and antioxidant vitamins on hyperhomocystinemia: A double-blind, randomized, factorial-design, controlled trial. Am J Clin Nutr. 1998;67:858–866. doi: 10.1093/ajcn/67.5.858. [DOI] [PubMed] [Google Scholar]
  • 62.Ridker PM. Homocysteine and risk of cardiovascular disease among postmenopausal women. JAMA. 1999;281:1817–1821. doi: 10.1001/jama.281.19.1817. [DOI] [PubMed] [Google Scholar]
  • 63.Osganian SK. Distribution of and factors associated with serum homocysteine levels in children child and adolescent trial for cardiovascular health. JAMA. 1999;281:1189–1196. doi: 10.1001/jama.281.13.1189. [DOI] [PubMed] [Google Scholar]
  • 64.Vos E. Multivitamin supplements are effective and inexpensive agents to lower homocysteine levels. Arch Intern Med. 2001;161:774. doi: 10.1001/archinte.161.5.774. [DOI] [PubMed] [Google Scholar]
  • 65.Wald DS. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med. 2001;161:695–700. doi: 10.1001/archinte.161.5.695. [DOI] [PubMed] [Google Scholar]
  • 66.Chait A, Malinow MR, Nevin DN, Morris CD, Eastgard RL, Kris-Etherton P. Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease. Am J Clinical Nutrition. 1999;70:881–887. doi: 10.1093/ajcn/70.5.881. [DOI] [PubMed] [Google Scholar]
  • 67.Brouwer IA, van Dusseldorp M, Thomas CM, Duran M, Hautvast JG, Eskes TK. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clinical Nutrition. 1999;69:99–104. doi: 10.1093/ajcn/69.1.99. [DOI] [PubMed] [Google Scholar]
  • 68.Malinow MR. Reduction of plasma homocysteine levels by breakfast cereal fortified with folic acid in patients with coronary heart disease. N England J Med. 1998:338. doi: 10.1056/NEJM199804093381501. [DOI] [PubMed] [Google Scholar]
  • 69.MacLenna A. Antiphospholipid syndrome: Clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients. Arthritis Rheumatism. 2002;46:1019–1027. doi: 10.1002/art.10187. [DOI] [PubMed] [Google Scholar]
  • 70.Harrison H, Berg L, Berg D. Polygenic contributions of procoagulant genetic factors in chronic fatigue syndrome and related chronic illnesses. University of Arizona College of Medicine and HEMEX Laboratories, Phoenix, Arizona. Updated April 17, 2002. Genetics Med 2002 (accepted for publication).
  • 71.Berg D, Berg L, Couvaras J, Harrison H. Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphopholipid antibody syndrome: An explanatory model and approach to laboratory diagnosis. Blood Coag Fibrinol. 1999;10:435–438. doi: 10.1097/00001721-199910000-00006. [DOI] [PubMed] [Google Scholar]
  • 72.Sumi H, Seiki M, Morimoto N, Tsushima H, Maruyama M, Mihara H. Plasma fibrinolysis after intradudenal adminstration of urokinase in rats. Enzyme. 1985;33:121–127. [PubMed] [Google Scholar]
  • 73.Toki N, Sumi H, Sasaki K, Boreisha I, Robbins KC. Transport of urokinase across the intestinal tract of normal human subjects with stimulation of synthesis and/or release of urokinase-type proteins. J Clin Invest. 1985;75:1212–1222. doi: 10.1172/JCI111818. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Yabe K, Bull Coll Agr Tokyo University. National Federation of cooperatives on Natto. In: A Historical record of Natto, p. 19. ed. Food pionia, Natto Research Center, Tokyo 1977.
  • 75.Sumi H, Hamada H, Tsushima H, Mihara H. A novel fibrinolytic enzyme(nattokinase) in the vegetable chees natto: A typical and popular soybean food in the Japanese diet. Experimentia. 1987;43:1110–1111. doi: 10.1007/BF01956052. [DOI] [PubMed] [Google Scholar]
  • 76.Sasaki K, Moriyama S, Sumi H, Toki N, Robbins K. The transport of 125 I-labeled human high molecular weight urokinase across the intestinal tract in a dog model with stimulation of synthesis and/or release of plasminogen activators. Blood. 1985;66:67–75. [PubMed] [Google Scholar]
  • 77.Sumi H, Sasaki K. Oral adminstration of urokinase. Paris: 17th International Congress of Hematology; 1978. p. 327.
  • 78.Sumi H, Toki N, Sasaki K, Robbins K. Oral adminstration of urokinase. Thrombi Res. 1980;20:711–714. doi: 10.1016/0049-3848(80)90161-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Chiropractic Medicine are provided here courtesy of National University of Health Sciences

RESOURCES